Eistland - eistneska - Ravimiamet

csl behring gmbh - von willebrandi faktor+viii hüübimisfaktor - süste-/infusioonilahuse pulber ja lahusti - 600rÜ+250rÜ 1tk

Eistland - eistneska - Ravimiamet

teva gmbh - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 100tk; 120mg 14tk

Eistland - eistneska - Ravimiamet

teva gmbh - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 168tk

Evrópusambandið - eistneska - EMA (European Medicines Agency)

celgene europe ltd. - romidepsiin - lümfoom, mitte-hodgkini - antineoplastilised ained - ravi perifeersete t-rakulise lümfoomi (ptcl),.

Evrópusambandið - eistneska - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Eistland - eistneska - Ravimiamet

cangene corporation - tuulerõugete immunoglobuliin - süstelahus - 125rÜ 1.2ml 1.2ml 1tk

Eistland - eistneska - Ravimiamet

sandoz pharmaceuticals d.d. - gemtsitabiin - infusioonilahuse kontsentraat - 40mg 1ml 5ml 5tk; 40mg 1ml 5ml 10tk; 40mg 1ml 50ml 1tk; 40mg 1ml 5ml 1tk; 40mg 1ml 25ml 1tk

Eistland - eistneska - Ravimiamet

krka d.d. novo mesto - gliklasiid - toimeainet modifitseeritult vabastav tablett - 90mg 30tk; 90mg 10tk; 90mg 60tk

Eistland - eistneska - Ravimiamet

teva b.v. - gliklasiid - toimeainet modifitseeritult vabastav tablett - 60mg 120tk; 60mg 10tk; 60mg 30tk

Evrópusambandið - eistneska - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastilised ained - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.